Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome

Heart Rhythm

Volumn 10, Issue 7, 2013, Pages 1054-1062

  Minoura, Yoshino ^a   Panama, Brian K ^a   Nesterenko, Vladislav V ^a   Betzenhauser, Matthew ^a   Barajas Martínez, Hector ^a   Hu, Dan ^a   Di Diego, José M ^a   Antzelevitch, Charles ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Cardiac arrhythmias; Positive inotropic effect; Sudden death; Transient outward potassium channel current

Indexed keywords

CARDIOVASCULAR AGENT; HERBACEOUS AGENT; NS 5806; QUINIDINE; TYRAMINE; UNCLASSIFIED DRUG; WENXIN KELI;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; BRUGADA SYNDROME; CALCIUM CURRENT; CHINESE HERB; CONTROLLED STUDY; DOG; DRUG EFFICACY; DRUG MECHANISM; ELECTROCARDIOGRAPHY; ENDOCARDIUM; EPICARDIUM; GENETIC PREDISPOSITION; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE CONTRACTILITY; NONHUMAN; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BRUGADA SYNDROME; DISEASE MODELS, ANIMAL; DOGS; DRUGS, CHINESE HERBAL; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; QUINIDINE;

EID: 84879502996     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.03.011     Document Type: Article

References (31)

1. A. Burashnikov, A. Petroski, D. Hu, H. Barajas-Martinez, and C. Antzelevitch Atrial-selective inhibition of sodium channel current by Wenxin Keli is effective in suppressing atrial fibrillation Heart Rhythm 9 2012 125 131
2. F. Zhou, S.J. Hu, and Y. Mu [Protection effect of Wenxin Keli on isoproterenol induced heart failure in rats] Zhongguo Zhong Yao Za Zhi 32 2007 1676 1679
3. Y.W. Liu, J.H. Guo, P. Zhang, and C. Li The effects of nardostachys chinensis beta 1 extract on the sodium current and transient outward potassium current of rat ventricular myocytes Chin J Cardiac Pacing Electrophysiol 23 2009 533 535
4. Q.Z. Tang The effect of NcBe from Buchangwenxin on potassium channels in single rabbit ventricular myocytes Chin Physician Tribune 9 2008 56 57
5. X. Wang, X. Wang, Y. Gu, T. Wang, and C. Huang Wenxin Keli attenuates ischemia-induced ventricular arrhythmias in rats: involvement of L-type calcium and transient outward potassium currents Mol Med Rep 7 2013 519 524
6. G.X. Yan, and C. Antzelevitch Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation Circulation 100 1999 1660 1666
7. J.M. Fish, D.R. Welchons, Y.S. Kim, S.H. Lee, W.K. Ho, and C. Antzelevitch Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome Circulation 113 2006 1393 1400
8. Y. Minoura, J.M. Di Diego, and H. Barajas-Martinez Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants J Cardiovasc Electrophysiol 23 2012 423 432
9. J.M. Di Diego, and C. Antzelevitch Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues: does activation of ATP-regulated potassium current promote phase 2 reentry? Circulation 88 1993 1177 1189
10. H. Barajas-Martinez, D. Hu, and T. Ferrer Molecular genetic and functional association of Bugada and early repolarization syndromes with S422L missense mutation in KCNJ8 Heart Rhythm 9 2012 548 555
11. K. Calloe, J.M. Cordeiro, and J.M. Di Diego A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome Cardiovasc Res 81 2009 686 694
12. C. Antzelevitch, and G.X. Yan J wave syndromes Heart Rhythm 7 2010 549 558
13. J.M. Di Diego, S. Sicouri, R.C. Myles, F.L. Burton, G.L. Smith, and C. Antzelevitch Optical and electrical recordings from isolated coronary-perfused ventricular wedge preparations J Mol Cell Cardiol 54 2013 53 64
14. A.C. Zygmunt, R.J. Goodrow, and C. Antzelevitch Sodium effects on 4-aminopyridine-sensitive transient outward current in canine ventricular cells Am J Physiol 272 1997 H1 H11
15. O.P. Hamill, A. Marty, E. Neher, B. Sakmann, and F.J. Sigworth Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches Pflugers Arch 391 1981 85 100
16. R. Dumaine, J.A. Towbin, and P. Brugada Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent Circ Res 85 1999 803 809
17. to) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome Heart Rhythm 8 2011 1024 1032
18. L.M. Qin, Y.F. Yan, and Z.C. Wang [Experimental study on the cardiotonic action of extract from Codonopsis pilosula (Franch.) Nannf] Zhongguo Zhong Yao Za Zhi 19 1994 238 240
19. +-ATPase activity Acta Pharmacol Sin 30 2009 61 69
20. R. Subashini, S. Yogeeta, A. Gnanapragasam, and T. Devaki Protective effect of Nardostachys jatamansi on oxidative injury and cellular abnormalities during doxorubicin-induced cardiac damage in rats J Pharm Pharmacol 58 2006 257 262
21. J.M. Fish, and C. Antzelevitch Role of sodium and calcium channel block in unmasking the Brugada syndrome Heart Rhythm 1 2004 210 217
22. J.M. Fish, and C. Antzelevitch Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome J Cardiovasc Electrophysiol 19 2008 301 308
23. S.H. Litovsky, and C. Antzelevitch Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol: a direct effect of acetylcholine in ventricular myocardium Circ Res 67 1990 615 627
24. C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada, K. Nademanee, and J. Towbin The Brugada syndrome In: Clinical Approaches to Tachyarrhythmias 1999 Futura Publishing Company Armonk, NY
25. B. Belhassen, S. Viskin, and C. Antzelevitch The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option? Pacing Clin Electrophysiol 25 2002 1634 1640
26. M. Alings, L. Dekker, A. Sadee, and A. Wilde Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome Pacing Clin Electrophysiol 24 2001 1420 1422
27. B. Belhassen, and S. Viskin Pharmacologic approach to therapy of Brugada syndrome: quinidine as an alternative to ICD therapy? C. Antzelevitch, P. Brugada, J. Brugada, The Brugada Syndrome: From Bench to Bedside 2004 Blackwell Futura Oxford 202 211
28. B. Belhassen, S. Viskin, R. Fish, A. Glick, I. Setbon, and M. Eldar Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome J Cardiovasc Electrophysiol 10 1999 1301 1312
29. J.S. Hermida, I. Denjoy, and J. Clerc Hydroquinidine therapy in Brugada syndrome J Am Coll Cardiol 43 2004 1853 1860
30. N.S. Mok, N.Y. Chan, and C.A. Chi-Suen Successful use of quinidine in treatment of electrical storm in Brugada syndrome Pacing Clin Electrophysiol 27 2004 821 823
31. Y. Mizusawa, H. Sakurada, M. Nishizaki, and M. Hiraoka Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment J Cardiovasc Pharmacol 47 2006 359 364